BackApplied Genetic Technologies Overview

Applied Genetic Technologies Current Cash

Track Applied Genetic Technologies's current cash ($34M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$34.24M
↓ 62.17% YoYΔ $-56.27M vs prior year quarter

Peer average / median

Loading

Applied Genetic Technologies Current Cash History

Loading

Applied Genetic Technologies vs. peers: Current Cash Comparison

Loading

Applied Genetic Technologies Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Applied Genetic Technologies (AGTC) FAQ

Applied Genetic Technologies (AGTC) currently reports a current cash of $34M as of September 2022. That compares with $91M in the prior-year period — down 62.2% year over year. Use the charts on this page to explore Applied Genetic Technologies's current cash history and peer comparisons.

Applied Genetic Technologies's current cash decreased from $91M to $34M — a 62.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Applied Genetic Technologies reported $34M in current cash as of September 2022. That compares with $91M in the prior-year period — down 62.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Applied Genetic Technologies, and consider following AGTC for alerts when major investors trade the stock.

Applied Genetic Technologies is classified in the Healthcare sector. On current cash, it currently shows $34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGTC with unrelated industries.